Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53

被引:2
|
作者
Klett, Theresa [1 ]
Schwer, Martin [1 ]
Ernst, Larissa N. [1 ]
Engelhardt, Marc U. [1 ]
Jaag, Simon J. [2 ]
Masberg, Benedikt [2 ]
Knappe, Cornelius [2 ]
Laemmerhofer, Michael [2 ]
Gehringer, Matthias [3 ,4 ]
Boeckler, Frank M. [1 ,5 ]
机构
[1] Eberhard Karls Univ Tubingen, Inst Pharmaceut Sci, Dept Pharm & Biochem, Lab Mol Design & Pharmaceut Biophys, Morgenstelle 8 Haus B, D-72076 Tubingen, Germany
[2] Eberhard Karls Univ Tubingen, Inst Pharmaceut Sci, Dept Pharm & Biochem, Pharmaceut Bio Anal, D-72076 Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Inst Pharmaceut Sci, Dept Pharm & Biochem, Pharmaceut Chem, D-72076 Tubingen, Germany
[4] Eberhard Karls Univ Tubingen, Inst Biomed Engn, Med Chem, D-72076 Tubingen, Germany
[5] Eberhard Karls Univ Tubingen, Interfac Inst Biomed Informat IBMI, D-72076 Tubingen, Germany
来源
关键词
covalent fragment-based drug discovery; differential scanning fluorimetry; 5; 5'-dithiobis-(2-nitrobenzoic acid); intact protein mass spectrometry; glutathione; ENRICHED FRAGMENT LIBRARIES; ACTIVATED PROTEIN-KINASES; MUTANT P53; CRYSTAL-STRUCTURE; NITROGEN-HETEROCYCLES; STRUCTURAL BASIS; DRUG DISCOVERY; CORE DOMAIN; INHIBITORS; CANCER;
D O I
10.2147/DDDT.S466829
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Purpose: Over the last few years, covalent fragment-based drug discovery has gained significant importance. Thus, striving for more warhead diversity, we conceived a library consisting of 20 covalently reacting compounds. Our covalent fragment library (CovLib) contains four different warhead classes, including five alpha-cyanoacacrylamides/acrylates (CA), three epoxides (EO), four vinyl sulfones (VS), and eight electron-deficient heteroarenes with a leaving group (SNAr/SN). Methods: After predicting the theoretical solubility of the fragments by LogP and LogS during the selection process, we determined their experimental solubility using a turbidimetric solubility assay. The reactivities of the different compounds were measured in a high-throughput 5,5'-dithiobis-(2-nitrobenzoic acid) DTNB assay, followed by a (glutathione) GSH stability assay. We employed the CovLib in a (differential scanning fluorimetry) DSF-based screening against different targets: c-Jun N-terminal kinase 3 (JNI(3), ubiquitin-specific protease 7 (USP7), and the tumor suppressor p53. Finally, the covalent binding was confirmed by intact protein mass Results: In general, the purchased fragments turned out to be sufficiently soluble. Additionally, they covered a broad spectrum of reactivity. All investigated alpha-cyanoacrylamides/acrylates and all structurally confirmed epoxides turned out to be less reactive compounds, possibly due to steric hindrance and reversibility (for alpha-cyanoacrylamides/acrylates). The SNAr and vinyl sulfone fragments are either highly reactive or stable. DSF measurements with the different targets JNI(3, USP7, and p53 identified reactive fragment hits causing a shift in the melting temperatures of the proteins. MS confirmed the covalent binding mode of all these fragments to USP7 and p53, while additionally identifying the SNAr-type electrophile SN002 as a mildly reactive covalent hit for p53. Conclusion: The screening and target evaluation of the CovLib revealed first interesting hits. The highly cysteine-reactive fragments VS004, SN001, SN006, and SN007 covalently modify several target proteins and showed distinct shifts in the melting temperatures up to +5.1 degrees C and -9.1 degrees C.
引用
收藏
页码:2653 / 2679
页数:27
相关论文
共 37 条
  • [21] Discovery of novel, potent USP7 inhibitors that upregulate p53 leading to anti-proliferative effects in cancer cells.
    Futran, Alan
    Lu, Tao
    Amberg-Johnson, Katherine
    Yang, Xiaoxiao
    He, Saidi
    Bell, Jeffrey
    Boyce, Sarah
    Dahlgren, Markus
    Dingley, Karen
    Fang, Liping
    Koldsoe, Heidi
    Konst, Zef
    Lin, Fang-Yu
    Pelleltier, Robert
    Qian, Heng
    Svensson, Mats
    Trzoss, Michael
    Xu, Jie
    Xu, Shuping
    Xu, Zhaowu
    Yapici, Engin
    Zhang, Yan
    Xing, Li
    Suzuki, Takao
    Huang, Xianhai
    Xu, Jiayi
    Wright, Hamish
    Jensen, Kristian
    Tang, Wayne
    Guo, Tao
    Akinsanya, Karen
    Madge, David
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation
    Bian, Saiyan
    Ni, Wenkai
    Zhu, Mengqi
    Zhang, Xue
    Qiang, Yuwei
    Zhang, Jianping
    Ni, Zhiyu
    Shen, Yiping
    Qiu, Shi
    Song, Qianqian
    Xiao, Mingbing
    Zheng, Wenjie
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (03): : 1022 - 1038
  • [23] ATM-Dependent Downregulation of USP7/HAUSP by PPM1G Activates p53 Response to DNA Damage
    Khoronenkova, Svetlana V.
    Dianova, Irina I.
    Ternette, Nicola
    Kessler, Benedikt M.
    Parsons, Jason L.
    Dianov, Grigory L.
    MOLECULAR CELL, 2012, 45 (06) : 801 - 813
  • [24] Helicobacter pylori affects the cellular deubiquitinase USP7 and ubiquitin-regulated components TRAF6 and the tumour suppressor p53
    Coombs, Nina
    Sompallae, Ramakrishna
    Olbermann, Patrick
    Gastaldello, Stefano
    Goeppel, Daniela
    Masucci, Maria G.
    Josenhans, Christine
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 301 (03) : 213 - 224
  • [25] USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer
    Yu-Ting Huang
    An-Chieh Cheng
    Hui-Chi Tang
    Guo-Cheng Huang
    Ling Cai
    Ta-Hsien Lin
    Kou-Juey Wu
    Ping-Hui Tseng
    Greg G. Wang
    Wei-Yi Chen
    Cell Death & Disease, 12
  • [26] INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS
    Carra, G.
    Panuzzo, C.
    Crivellaro, S.
    Torti, D.
    Parvis, G.
    Familiari, U.
    Volante, M.
    Morena, D.
    Lingua, M. F.
    Brancaccio, M.
    Guerrasio, A.
    Pandolfi, P. P.
    Saglio, G.
    Taulli, R.
    Morotti, A.
    HAEMATOLOGICA, 2016, 101 : S78 - S78
  • [27] USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer
    Huang, Yu-Ting
    Cheng, An-Chieh
    Tang, Hui-Chi
    Huang, Guo-Cheng
    Cai, Ling
    Lin, Ta-Hsien
    Wu, Kou-Juey
    Tseng, Ping-Hui
    Wang, Greg G.
    Chen, Wei-Yi
    CELL DEATH & DISEASE, 2021, 12 (10)
  • [28] INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS
    Carra, G.
    Panuzzo, C.
    Crivellaro, S.
    Torti, D.
    Parvis, G.
    Familiari, U.
    Volante, M.
    Morena, D.
    Lingua, M. F.
    Brancaccio, M.
    Guerrasio, A.
    Pandolfi, P. P.
    Saglio, G.
    Taulli, R.
    Morotti, A.
    HAEMATOLOGICA, 2016, 101 : 421 - 421
  • [29] The PICT-1 is required for USP7 to effectively stabilize p53 protein, and codon 389 polymorphism is a risk factor for ovarian cancer
    Yoshimoto, Masafumi
    Tokuda, Aoi
    Yaginuma, Yuji
    CANCER RESEARCH, 2017, 77
  • [30] Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway
    Yi, Lei
    Cui, Yan
    Xu, Qingfu
    Jiang, Yugang
    ONCOLOGY REPORTS, 2016, 36 (05) : 2935 - 2945